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ABSTRACT 
Photodynamic therapy (PDT) is a technique that has been used for the treatment of tumors, especially in 
Gynecology. The photodynamic reaction is based on the production of reactive oxygen species after the 
activation of a photosensitizer. Advantages of the PDT in comparison to the surgical resection are: 
ambulatory treatment and tissue recovery highly satisfactory, through a non-invasive procedure. The cervical 
intraepithelial neoplasia (CIN) grades I and II presents potential indications for PDT. The aim of the proposed 
study is to evaluate the safety and efficacy of the PDT for the diagnostics and treatment of CIN I and II. The 
equipment and the photosensitizer are produced in Brazil with a representative low cost. It is possible to 
visualize the fluorescence of the cervix and to treat the lesions, without side effects. The proposed clinical 
protocol shows great potential to become a public health technique. 
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1. INTRODUCTION 
The cervical cancer is a major public health problem, especially in developing countries like Brazil. It 
is still the second leading cancer in women over the incident in Brazil and worldwide [1, 2]. For Brazil, in 2012, 
it was estimated 17,540 new cases of cervical cancer, with an estimated risk of 17 cases per 100,000 women. 
Excluding tumors of non-melanoma skin cancer of the cervix is the most frequent in the North (24/100 000) 
region. In the Midwest (28/100 000) and Northeast (18/100 000) occupies the second most frequent position 
in the Southeast (15/100 000), the third region, and the southern region (14/100 000), fourth [2]. 
About 90% of cervical cancers originate in the evolution of cervical intraepithelial neoplasia (CIN). 
CIN is classified on the basis of cyto-histological characteristics, grade I (low-grade lesion) and grades II and 
III (high grade lesions). It is a chronic disease with intra-epithelial changes, which in an average 5-6 years will 
turn into invasive lesion.  
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Although several medical treatments, prevalence studies of type-specific HPV for immunization [3] 
and medications are available, no single treatment can be considered effective in eliminating warty lesions 
and preventing them from recurring [4]. In addition, HPV vaccination will be most beneficial in resource-poor 
countries lacking organized screening programs, where cervical cancer remains a major cause of cancer-
related death in women [5]. The scenery of our country forces us for actions like this: the development of new 
strategies to trace the infection, to combat its consequences and to guide women with HPV. 
The main current application of PDT is in the treatment of nonmelanoma skin cancer, and other 
applications which already shown effectiveness is in carcinomas of the mouth, esophagus, bladder, lung, 
colorectal, among others [6-10]. The PDT is the use of a photosensitizing agent that displays selectivity 
changed cells and when activated by a light source, promotes the production of reactive oxygen species 
(ROS - reactive oxygen species), highly toxic to the cell, inducing the death of abnormal tissue. The 
application of the photosensitizer intravenously results in a period of the patient's skin photosensitivity during 
four to eight weeks. This is the main adverse effect of systemic PDT. 
The application of cream to the cervix enables delivery of the prodrug, methyl aminolevulinate 
(methyl-ALA), which penetrate the cell and induce protoporphyrin IX (PpIX) formation. Studies have 
demonstrated that the production and accumulation of PpIX occurs more efficiently in altered and neoplastic 
cells than in normal cells. The PpIX molecule is highly fluorescent, or when it absorbs energy, the decay of 
the excited electronic state result in photon emission, or fluorescence.  
2. MATERIAL AND METHODS 
2.1 Patients 
Patients with confirmatory diagnosis of cervical intraepithelial neoplasia (CIN) grades I and II, bearing 
or not the HPV virus or HIV are selected and invited to participate in this study.  The patients will be subjected 
to photodynamic therapy (PDT) and divided in two groups: Group 1 with CIN - I and Group - 2 with CIN II. 
2.2 Casuistry  
This is a clinical study that has been realized between April 2012 and April 2013. The patient 
selection was consecutive, non-random, decided by the clinicians involved in the research and with biopsy 
confirmed by the CIN presence, grades I and II. Written informed consent was obtained following approval by 
the Human Medical Ethics Committee.  
2.3 The Photosensitizer 
A cream containing the prodrug methyl aminolevulinate (MAL) is used. This compound penetrates the 
cells and in the mitochondria induces the formation of the photosensitizer protoporphyrin IX (PpIX) locally. 
The active ingredient MAL is produced by the company PDTPharma (Cravinhos, Sao Paulo, Brazil) 
incorporated in an oil/water cream at a concentration of 20% (w/w). Using a gynecological applicator or a 
needleless syringe, 2 grams of the cream is applied and a tampon is used to keep the cream in place for one 
to three hours. 
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2.4 Photodynamic Therapy 
After one or three hours (groups 1 and 2, respectively) of the cream application containing methyl 
aminolevulinate (MAL), fluorescence images of the photosensitizer protoporphyrin IX (PpIX) are obtained with 
the probe laser emitting at 400 nm. After the registration of images another tip with LEDs (light-emitting 
diodes) emitting at 630 nm is anatomically positioned covering the entire cervix. The equipment used in this 
study is a prototype named "CERCA" produced by MMOptics (São Carlos, Sao Paulo, Brazil). The patients of 
the group 1 are treated during 21 minutes, with an intensity of 80 mW/cm2. The same time of application is 
done for the patients of the group 2, however with and intensity of 120 mW/cm2.  After PDT, new optical 
fluorescence detection is performed with the possibility to record the consumption of PpIX. 
2.5 Follow-up 
A follow-up session occurs at 30 and 90 days after treatment. Clinical evaluation by colposcopy is 
performed in all sessions. Visualization of auto fluorescence and the image data is acquired and material for 
cytology by Pap smear is collected. In case of a negative response of the cytology, a biopsy will be requiring. 
With the recording of fluorescence imaging and white light, a computational analysis to identify 
patterns of fluorescence emission of the CIN lesion region will be taken. The results obtained from images will 
be compared to histopathology results to validate the method of photodynamic diagnosis. 
 
3. RESULTS AND DISCUSSION 
A preliminary phase of the project (from January to April 2012) was the planning of the prototype 
(Figure 1) based on our experience with photodynamic therapy for the treatment of condyloma by HPV [8], 
skin cancer [9] and photodiagnosis [10]. The prototype has been designed containing a basic electronic 
control  and LEDs in two different tips, one for fluorescence diagnosis (Figure 2, panel A), and another for 
treatment (Figure 2, panel B).  
 
Fig. 01: Image (illustration) of the device at the first model of the prototype. 
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Fig. 02: Panel A – representative illustration of the tips used for photodiagnosis (left) and for the treatment (right). Panel B 
– other side of view (front) of the device.  
The initial challenge was to establish the anatomical dimensions of the treatment tip and to choose 
the details of the clinical protocol, as irradiance and time of exposure of both: he cream and the light (Figure 
3). 
 
Fig. 03: A schematic figure of the procedure.  
 
The results after treatment with a session of PDT demonstrated a complete response (negative for 
CIN) in 100% of the 23 patients treated. The Pap smear results were negative for CIN I and/or II and no 
biopsy was necessary. 
A B 
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The mean age was 26 year old and 83% of the patients are younger than 30 years (Table 1). 
Case Group 1 Group 2 Age Positive Response 
Negative 
Response 
1 x  22 x  
2  x 25 x  
3  x 37 x  
4  x 15 x  
5  x 20 x  
6  x 21 x  
7 x  27 x  
8 x  26 x  
9 x  21 x  
10 x  19 x  
11  x 29 x  
12  x 22 x  
13 x  27 x  
14 x  36 x  
15 x  21 x  
16 x  25 x  
17  x 29 x  
18 x  28 x  
19  x 31 x  
20 x  19 x  
21 x  57 x  
22 x  16 x  
23 x  24 x  
 
Table 1: Patients main facts and outcome information 30 days after PDT, by cytology confirmation. 
 
Was observed that in the major of all cases, the fluorescence of the cervix of patients in group 1 (CIN 
I and time of MAL cream contact of one hour) is more selective in the squamo-columnar junction, and less 
intense in all cervix (Figure 4, panel A). The most intense fluorescence was observed in the cervix of patients 
in group 2 (CIN II and three hours of MAL cream contact), with all cervix presenting an intense PpIX 
fluorescence (Figure 5, panel A). 
After PDT a significant PpIX photodegradation was observed in both clinical trials, with no 
macroscopic changes of the cervix and no pain during and after illumination (Figures 4 and 5, panels B). 
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Fig. 04: Cervix images of a patient Group 1. Panel A – PpIX fluorescence into the cervix, one hour after MAL cream 
application. Panel B – Cervix fluorescence after PDT (80 mW/cm2, during 21 minutes, total dose of 100 J/cm2). 
 
Fig. 05: Cervix images of a patient Group 2. Panel A – PpIX fluorescence into the cervix, three hours after MAL cream 
application. Panel B – Cervix fluorescence after PDT (120 mW/cm2, during 21 minutes, total dose of 150 J/cm2). 
Is necessary to improve the system for detection of the images. All these pictures were acquired 
using a camera with 8 megapixels of a Sony Xperia Cell Phone model “P”.   
 
4. CONCLUSIONS 
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The PDT is considered a very attractive technique for the treatment of malignant lesions at an early 
stage, especially for developing countries. The main reasons for this position are: 
1. Methodology noninvasive and very satisfactory healing response. 
2. Simple and portable instrumentation. In this project we use a system with Brazilian technology, 
which further result in lower costs. 
3. Pharmaceutical compounds produced by a Brazilian company. Likewise the equipment, the future 
cost of a Brazilian drug will be much lower than the available imported. 
4. Treatment on an ambulatory without the need for anesthesia or hospitalization of the patient. 
5. Single treatment protocol with an evaluation conducted, without necessity for complex medical 
training. 
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